Two Digital Events From the Contact Lens Institute Will Examine Inflation’s Impact on Eyecare

By Staff
Monday, November 7, 2022 12:18 AM WASHINGTON, D.C.—The Contact Lens Institute (CLI) has announced details for two digital events that will explore the intersection of inflation and eyecare, presenting data and insights from new U.S. consumer research. Taking place on Wednesday, Nov. 16, 2022, at 6:00 p.m. ET and 9:00 p.m. ET, the live online panels are open to all members of the eyecare community. Free registration is now available at SeeTomorrowNow.com. The Remarkable Resilience: Eye Care Insights for a Challenging Economy webinars center on the recently published CLI report surrounding patient beliefs and behaviors about eyecare choices, discretionary spending and contact lens habits.

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption in North America

By Staff
Friday, November 4, 2022 12:24 AM SAN RAMON, Calif.—Deepening its commitment to expand specialty contact lens adoption in North America and worldwide, CooperVision has added SynergEyes to its CooperVision Specialty EyeCare business unit. The Carlsbad, Calif.-based company is widely known for hybrid lens technologies and brands, which span the treatment of irregular cornea, presbyopia and astigmatism. Terms of the acquisition were not disclosed. The announcement pointed out that the development will broaden CooperVision’s already extensive range of products and services, creating a complete portfolio for the treatment of keratoconus and irregular cornea in North America and beyond, plus substantial opportunities to advance care for other common ocular conditions.

Johnson & Johnson Vision Receives Approval in Canada for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management

By Staff
Wednesday, October 26, 2022 12:18 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision, part of the Johnson & Johnson MedTech received approval from Health Canada for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management.

Johnson & Johnson Reports Sales Increased 1.9 Percent to $23.8 Billion in the Third Quarter as U.S. Vision Care Shows 8.6 Percent Growth

By Staff
Wednesday, October 19, 2022 12:18 AM NEW BRUNSWICK, N.J.—Johnson & Johnson reported Tuesday that its sales in the third quarter increased 1.9 percent to $23.8 billion, with operational growth of 8.1 percent and adjusted operational growth of 8.2 percent.

With Halloween Approaching, Contact Lens Safety Is Top of Mind

By Mary Kane
Friday, October 14, 2022 8:30 AM With Halloween just two weeks away, it’s a good time for ECPs to talk with patients about contact lens safety and the dangers of wearing lenses that are dispensed without an eye exam or a prescription. According to the Food and Drug Administration, wearing decorative contact lenses can be risky and wearing any kind of contact lenses, including decorative ones, can cause serious damage to your eyes if the lenses are obtained without a prescription or are not used correctly. Here are some of the things that can go terribly wrong with your eyes when wearing decorative or cosmetic contact lenses sold in stores or online.

Prevent Blindness Declares October Is Contact Lens Safety Month

By Staff
Tuesday, October 4, 2022 12:27 AM CHICAGO—Prevent Blindness has declared October as Contact Lens Safety Month to help educate the public on the best ways to protect their eyes through proper care. In addition to a dedicated webpage, fact sheets and shareable social media graphics, Prevent Blindness also offers the “Contact Lens Safety” episode as part of the Focus on Eye Health Expert Series. Dr. Thomas L. Steinemann, professor of ophthalmology at Case Western Reserve University, discusses a variety of topics with Prevent Blindness president and CEO, Jeff Todd, including advocating for contact lens safety, patient care, and the dangers of improper use of contact lenses.

CooperVision Specialty EyeCare Appoints Weiwen Chen to Lead Asia-Pacific Region Expansion

By Staff
Tuesday, September 27, 2022 12:18 AM SAN RAMON, Calif.—CooperVision Specialty EyeCare has named Weiwen Chen as business manager, Asia-Pacific. In this newly-created role, she will lead the organization’s rapid growth and category expansion across the region.

FTC Returning More Than $1.9 Million to Consumers Nationwide Who Purchased Hubble Contact Lenses Without Properly Obtained or Verified Rx

By Staff
Wednesday, September 7, 2022 12:21 AM WASHINGTON D.C.—The Federal Trade Commission said last week it is sending payments totaling more than $1.9 million to 30,172 consumers nationwide who bought Hubble brand contact lenses from Vision Path, Inc.

Bausch Health Says It Continues the Process Toward Separating Bausch + Lomb Eye Health Business

By Staff
Friday, August 26, 2022 12:24 AM LAVAL, Quebec—Bausch Health Cos. (NYSE/TSX: BHC) said this week that it has transferred common shares in an amount equal to approximately 38.6 percent of the issued and outstanding shares of Bausch + Lomb Corp. to an existing wholly owned unrestricted subsidiary of Bausch Health. This transfer is consistent with the company's “commitment to the separation of Bausch + Lomb and provides the company with strategic flexibility while it evaluates all relevant factors and considerations relating to the separation of Bausch + Lomb,” the Bausch Health announcement noted.

CooperVision Costa Rica Manufacturing Facility Earns Prestigious LEED Gold Certification

By Staff
Tuesday, August 16, 2022 12:24 AM SAN RAMON, Calif.—In recognition of its continued leadership in sustainability, CooperVision’s contact lens manufacturing facility in Alajuela, Costa Rica, has been elevated to the prestigious LEED Gold status following program recertification from U.S. Green Building Council (USGBC). It is the most widely used green building rating system in the world.

Alcon Says it Is ‘Launching New Products and Gaining Share’ as Second-Quarter Results Show Sales and Margin Increases

By Staff
Thursday, August 11, 2022 12:24 AM GENEVA—Alcon (SIX/NYSE:ALC) said this week that its second-quarter sales increased 5 percent on a reported basis to $2.2 billion, and noted that the increase was 10 percent on a constant currency basis. Sales in both surgical and vision care in the second quarter ended June 30 benefited from “product innovation, continued recovery across international markets from the COVID-19 pandemic and sales from acquired products,” the company’s announcement noted.

Art Optical Announces Specialty Contact Lens Student/Resident Travel Grant Program for 2023

By Staff
Monday, August 8, 2022 12:18 AM GRAND RAPIDS, Mich.—Art Optical Contact Lens Inc., a leading provider of custom contact lenses, has announced a travel grant opportunity for optometry students and residents for 2023. As a dedicated supporter of optometric education and to encourage students with an interest in specialty contact lenses, Art Optical will award up to six travel grants, valued at $750 each, to attend a specialty contact lens meeting.

Growth in Vision Care Helps Boost Bausch + Lomb's Overall Performance in the Second Quarter

By Staff
Friday, August 5, 2022 12:30 AM VAUGHAN, Ontario—Bausch + Lomb Corp. (NYSE/TSX: BLCO) reported Thursday that its second-quarter revenue increased 1 percent (on a reported basis) to $941 million, and approximately 6 percent organically, “driven by strong performance in vision care and surgical segments.” The year-ago revenue total was $934 million. Foreign exchange had an unfavorable impact on revenues of $46 million in the second quarter, the company noted. In the vision care segment, revenue totaled $589 million in the second quarter, which compares with $556 million in the second quarter of 2021, an increase of $33 million, or 6 percent.

Specialty Contact Lens Innovator Daddi Fadel Joins CORE

By Staff
Friday, August 5, 2022 12:21 AM WATERLOO, Ontario—Specialty contact lens innovator Daddi Fadel, DOptom, FSLS, FBCLA, FAAO, FIACLE, will join the Centre for Ocular Research & Education (CORE) in September 2022.

Alcon Strengthens Research and Development Team With Addition of Dr. Edward J. Holland

By Staff
Thursday, August 4, 2022 12:15 AM FORT WORTH, Texas—Alcon said recently that the world-renowned professor of ophthalmology Edward J. Holland, MD, will join the company as a member of the research and development (R&D) team. Dr. Holland is a thought-leader in ophthalmology, specializing in the field of cornea and the ocular surface, according to the company’s recent announcement. He will serve as an enterprise senior scientific advisor to Alcon while continuing his private practice. In his role with Alcon, Dr. Holland will be integral in providing strategic input on Alcon’s pipeline and portfolio, including ophthalmic pharmaceuticals.